SpineGuard's DSG® Technology Applied to Robotics: Three Scientific Articles Presented at the Conference on New Technologies for Computer and Robot Assisted Surgery (CRAS)
04 Mai 2022 - 06:00PM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company
that deploys its DSG® (Dynamic Surgical Guidance) sensing
technology to secure and streamline the placement of bone implants,
announced that research teams presented three articles at the CRAS
conference on April 25th and 26th in Naples, Italy. They report the
progress made with the robotic application of DSG.
Stéphane Bette, co-founder and Deputy CEO of SpineGuard,
said: "The acceptance of these articles in a reference
conference of the sector is a new validation by the scientific
community of the value and feasibility in using DSG to enhance
surgical robots in orthopedics. It also displays the richness of
our collaboration with ISIR and hospital practitioners, that
continues to our great satisfaction. We are delighted to see the
communication of the results of the first electrical conductivity
data collection in patient tissues as initiated late 2020 thanks to
DSG Connect. The analysis of such data is carrying significant
added value in the field of robotics in order to assist surgeries,
as much as in bone quality measurement to help with patient
treatment during and after the procedure."
DSG is based on the local measurement of electrical conductivity
of tissues in real time without X-ray imaging, with a sensor
located at the tip of the drilling instrument. Its efficacy was
proven by more than 85,000 surgeries across the globe and 19
scientific publications. SpineGuard has entered in 2017 a
collaboration with the ISIR (Institut des Systèmes Intelligents et
de Robotique) lab of Sorbonne University, CNRS and INSERM, for the
application of DSG to surgical robots and the enhancement of their
safety, accuracy, and autonomy.
CRAS (Conference on New Technologies for Computer and Robot
Assisted Surgery) founded in 2011 has become one of the most
recognized scientific conferences in the field of robot assisted
surgery. Its goals are to strengthen the collaboration between the
different research groups to boost the efficacy and shorten the
development cycle, in a context where numerous technologies
applicable to robotics have not made their way into operating rooms
yet.
Three papers were presented at CRAS conference:
1. The first paper, presented in plenary
session, is the fruit of the collaboration between Trousseau
Hospital, ISIR and SpineGuard. Entitled "Toward automatic bone
breach detection for spine surgery using tissue bio-electrical
conductivity sensing", it presents the outcomes of the first
intraoperative collection of tissue electrical conductivity data
during pedicle drillings in a series of scoliosis patients.
2. The second paper, presented as a poster
and entitled "Automatic bone breach detection for spine surgery
based on bio-electrical conductivity sensing: Ex-vivo experimental
validation" presents the results of bone breach detection and
automatic stop of a vertebral drilling performed by a robot.
3. The third one, in the form of a poster as
well, entitled "Force control of the KUKA LBR Med without external
force sensor" describes a specific control mode that allows the
robot to optimize utilization of DSG in order to detect the breach,
and to follow the respiratory motion cycle during drilling.
These two posters and described algorithms are the fruits of the
collaboration between SpineGuard and ISIR. Part of this work
received funding from the European Union’s Horizon 2020 research
and innovation program, in the context of the FAROS project
(Functional Accurate RObotic Surgery) under grant agreement No
101016985.
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 85,000 surgical
procedures worldwide. Nineteen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these strong fundamentals and several strategic
partnerships, SpineGuard has expanded the scope of its DSG®
technology in innovative applications such as the « smart » pedicle
screw, the DSG Connect visualization and registration interface,
dental implantology and surgical robotics. DSG® was co-invented by
Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain
Vanquaethem, Biomedical Engineer. SpineGuard has engaged in
multiple ESG initiatives.
For further information, visit www.spineguard.com
Disclaimer:
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220504005842/en/
SpineGuard Pierre Jérôme Président Directeur Général Tél.
: 01 45 18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi Directeur Financier Tél. : 01
45 18 45 19 m.lanfossi@spineguard.com
NewCap Relations Investisseurs & Communication
Financière Mathilde Bohin / Pierre Laurent Tél. : 01 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024